Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Flomax®
Date:7/22/2010

DETROIT, July 22 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has started shipping tamsulosin hydrochloride capsules. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These tamsulosin hydrochloride capsules are therapeutically equivalent to Flomax® Capsules 0.4 mg from Boehringer Ingelheim Pharmaceuticals, Inc. Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

Flomax® is a registered trademark of Astellas Pharma Inc.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limitation, the words "believe" or "expect" and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission, including Part I, Item 1A of our most recent Form 10-K, and include but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obt
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets
2. Caraco Pharmaceutical Laboratories, Ltd. Receives Notice Regarding NYSE Amex Continued Listing Standards
3. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
4. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Exelon® Capsules
5. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R)
6. Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride Injection
7. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution
8. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
10. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
11. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 A new report ... Latin America – Chile , ... are top targets for IVD firms.  The healthcare research ... heavily into IVD strategies for the Latin American continent with ... support globally distributed supply operations. However, the country,s regional economic ...
(Date:3/27/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... trauma patients. Available in both small (6mm) ... External Fixation System from Zimmer is a modular system that ... The XtraFix System allows surgeons to eliminate steps, ... process, resulting in saved time, costs and overall team effort. ...
(Date:3/27/2015)... -- CHINA AID, the 10 ... Medicine and Healthcare, second to none in ... at Shanghai New International Expo Center on 22-24 April. ... on Encouraging Private Capital to Participate in the Development ... by the Ministry of Civil Affairs of the ...
Breaking Medicine Technology:Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6
... Dec. 11 As Warner Chilcott plc (Nasdaq: ... global branded prescription pharmaceuticals business of The Procter & ... Acquisition"), constituted a change of control under a global ... P&G subsidiary acquired by Warner Chilcott and Sanofi-Aventis U.S. ...
... , IRVINE, Calif., Dec. 11 PRO-DEX, INC. (Nasdaq: ... Annual Shareholders Meeting held on December 4, 2009. At the ... Healey, David Holder and Mark Murphy as directors; (ii) approved the ... split if it should elect to do so at any time ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Association Annual Conference to be held April 10-11, ... Columbus, OH. , The OPTA Annual Conference ... products and services. , Representatives from Aureus ...
(Date:3/28/2015)... Virginia (PRWEB) March 28, 2015 ARDX will ... 28th from 12pm -3pm at the Chesapeake Conference Center in ... by sponsoring an empowering event for women in the Hampton ... Weaving the Stories of Women’s Lives. Women grow stronger ... from each other. This year the WWC™ theme is ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 The ... from dating experts Samantha Sanderson and Jason Rogers has ... buzz of media attention. The commotion surrounding the course's ... prompting him to publish an in-depth review of the ... when the men in their lives suddenly start pulling ...
(Date:3/27/2015)... York, New York (PRWEB) March 27, 2015 ... ( http://www.lipitorlawsuitcenter.com/ ) that allege the statin medication increases ... diabetes has granted Pfizer Inc.’s Motion to Dismiss four ... According to a Case Management Order issued in the ... 23rd, the Court determined that the dismissals were warranted ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 Healthpointe ... Stanley G. Katz, M.D., is now treating knee and ... including Anaheim , Long Beach, and La Mirada. ... of acute knee and hip joint disorders as well ... Katz is passionate in returning his patients back to ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3
... BMR, TORONTO, Nov. 10 /PRNewswire-FirstCall/ - Bradmer ... development and,commercialization of cancer therapies, today announced its ... Operational Highlights, During the three months ended ... date, the Company achieved the following milestones related ...
... November 10, 2008 Ewing sarcoma is the second ... children and young adults. Patients with relapsed or refractory ... Cytarabine decreases the levels of a certain key protein ... against Ewing sarcoma cell lines in the laboratory. Treatment ...
... 10 PARI Pharma GmbH has,successfully completed Phase ... PARI Tobramycin 100 (150mg/1.5mL) formulation delivered via a,customized ... with the PARI LC PLUS jet nebulizer. While ... difference was,a reduction in the average inhalation time ...
... the American,Diabetes Association there are 23.6 million children ... and approximately one million people are,diagnosed with the ... in the U.S. resulted in $116 billion in ... epidemic, Health Management Corporation,(HMC), a nationally recognized leader ...
... access, distrust of docs behind inequalities in treatment , , ... appropriate care and distrust of doctors are among the ... say. , Allergists were expected to discuss these issues ... the American Academy of Allergy, Asthma & Immunology (ACAAI) ...
... Services Partners,Inc. (OTC Bulletin Board: TTSPU) announced today ... Krishna as a director at its board meeting,held ... an experienced,health care entrepreneur, having started several companies. ... which assists U.S.,pharmaceutical companies perform Phase II clinical ...
Cached Medicine News:Health News:Bradmer announces 2008 third quarter operational and financial results 2Health News:Bradmer announces 2008 third quarter operational and financial results 3Health News:Bradmer announces 2008 third quarter operational and financial results 4Health News:Bradmer announces 2008 third quarter operational and financial results 5Health News:Bradmer announces 2008 third quarter operational and financial results 6Health News:Bradmer announces 2008 third quarter operational and financial results 7Health News:Bradmer announces 2008 third quarter operational and financial results 8Health News:Bradmer announces 2008 third quarter operational and financial results 9Health News:Bradmer announces 2008 third quarter operational and financial results 10Health News:PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 2Health News:PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 3Health News:PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 4Health News:Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife 2Health News:Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife 3Health News:Barriers to Good Asthma Care Detailed 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: